HB0017

· Huabo Biopharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HB0017, covering 2024-06-21 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of HB0017 in Psoriasis Patients [Phase 2]